« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 13, Issue 11
, Pages
1358-1368
, November 2007
Status of Donor-Recipient HLA Class I Ligands and Not the KIR Genotype Is Predictive for the Outcome of Unrelated Hematopoietic Stem Cell Transplantation in Beta-Thalassemia Patients
-
Kaplan-Meier probabilities of overall survival, thalassemia-free survival and cumulative incidence of mortality and rejection in 45 thalassemia patients transplanted from an unrelated donor.
Kaplan-Meier probabilities of overall survival, thalassemia-free survival and cumulative incidence of mortality and rejection in 45 thalassemia patients transplanted from an unrelated donor.
-
Influence of heterozygosity for the HLA-Cw ligand groups 1 and 2 (C1/C2) on the incidence of grade II-IV aGVHD in 45 thalassemia patients transplanted from an unrelated donor. (C1/C2 patients = 22, ev
Influence of heterozygosity for the HLA-Cw ligand groups 1 and 2 (C1/C2) on the incidence of grade II-IV aGVHD in 45 thalassemia patients transplanted from an unrelated donor. (C1/C2 patients = 22, events = 10; C1/C1 patients = 9, events = 0; C2/C2 patients = 14, events = 2).
-
Influence of homozygosity for the HLA-Cw ligand groups (C1/C1 or C2/C2) on the cumulative incidence of rejection in 45 thalassemia patients transplanted from an unrelated donor. (C1/C1 patients = 9, eInfluence of homozygosity for the HLA-Cw ligand groups (C1/C1 or C2/C2) on the cumulative incidence of rejection in 45 thalassemia patients transplanted from an unrelated donor. (C1/C1 patients = 9, events = 3; C2/C2 patients = 14, events = 4; C1/C2 patients = 22, events = 0).
-
Comparison of the probabilities of thalassemia-free survival (TFS) between 22 C1/C2 heterozygotes (events = 18) and 23 C1/C1 or C2/C2 homozygotes (C1/C1 patients = 9, events 6; C2/C2 patients = 14, evComparison of the probabilities of thalassemia-free survival (TFS) between 22 C1/C2 heterozygotes (events = 18) and 23 C1/C1 or C2/C2 homozygotes (C1/C1 patients = 9, events 6; C2/C2 patients = 14, events = 8).
-
Impact of the presence of the HLA-A11 KIR antigen on the incidence of grade II-IV aGVHD in 45 thalassemia patients transplanted from an unrelated donor. (HLA-A11 positive patients = 11, events = 0; HLImpact of the presence of the HLA-A11 KIR antigen on the incidence of grade II-IV aGVHD in 45 thalassemia patients transplanted from an unrelated donor. (HLA-A11 positive patients = 11, events = 0; HLA-A11 negative patients = 34, events 12).
PII: S1083-8791(07)00369-2
doi: 10.1016/j.bbmt.2007.07.011
© 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 13, Issue 11
, Pages
1358-1368
, November 2007
